I thought the announcement will come tomorrow morning, so I did not turn my computer on until now.
I were so shocked when seeing the share price down from 7.3c to 0.2c and I lost all my money like other shareholders. I was crying too, would not dare to tell my wife about this for long long time.
WHAT WAS WRONG?
- Did the manufacturer produce the drug VF00102 correctly for this clinical trial?
- The drug produced during TIS time worked. VF00102 failed. Why?
- Did the company test VF00102 on a sample of Australian patients to make sure it works as intended?
- The drug failed on venous leg ulcers, but it might work on diabetic leg ulcers.
- Can we sell this drug to other countries which do not require FDA or EU approval?
- Forums
- ASX - By Stock
- DLM
- Ann: Results of Phase 2 Clinical Trial
Ann: Results of Phase 2 Clinical Trial, page-93
-
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online